KenH
Well-Known Member
“Two existing drugs, created by a City of Hope scientist using advanced genomic technology, are being tested for their potential to fight the COVID-19 epidemic. One could be used to prevent the novel coronavirus infection, the other to stop the “cytokine storm,” an immune system overreaction that causes most COVID deaths.
Both drugs were developed by John J. Rossi, PH. D., Lidow Family Research Chair of the Department of Molecular and Cellular Biology at City of Hope, and his longtime collaborator Nagy A. Habib, M.D., of Imperial College, London.
These drugs are at the forefront of an exciting new class of medications called small activating RNAs, which transmit disease-fighting instructions to a part of the gene called a transcriptome, which then carries them out.”
COVID-19: Two groundbreaking drugs will combat the disease and its deadliest symptoms | City of Hope
Both drugs were developed by John J. Rossi, PH. D., Lidow Family Research Chair of the Department of Molecular and Cellular Biology at City of Hope, and his longtime collaborator Nagy A. Habib, M.D., of Imperial College, London.
These drugs are at the forefront of an exciting new class of medications called small activating RNAs, which transmit disease-fighting instructions to a part of the gene called a transcriptome, which then carries them out.”
COVID-19: Two groundbreaking drugs will combat the disease and its deadliest symptoms | City of Hope